Leading stem cell and exosome therapy research blog by Cell La Vie, Bangkok. Clinical insights, cost breakdowns, and regenerative treatment guides.
Traveling abroad for stem cell therapy is a transformative step. Patients seek innovative treatments for conditions like arthritis, neurological disorders, or chronic injuries. At Cell La Vie in Thailand, we offer world-class care. We guide international patients through this journey with safety and support. This comprehensive guide explains what to expect when traveling for stem […]
Read More »Discover the essential 5 questions to ask before embarking on Stem Cell Treatment. Get the insights you need to make informed decisions and ensure a successful experience. Don’t miss out on this crucial information!
Read More »2026 patient guide to MSC therapy for Alzheimer’s disease: how it differs from lecanemab and donanemab, who is a candidate, what outcomes to expect, the 6 active clinical trials including NCT06775964 and the first MSC + antibody drug combination trial.
Read More »Is Stem Cell Therapy Legal and Safe in Thailand? For international patients considering regenerative treatments, traveling abroad for stem cell therapy brings both immense hope and important practical questions. As medical tourism in Southeast Asia expands, Thailand—specifically Bangkok—has established itself as a leading global center for advanced cellular therapies. However, prospective patients from the United […]
Read More »Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026, who qualifies, and what options exist in Thailand now.
Read More »5 MSC and exosome trials for psoriasis have reported completion; three 2026 mechanistic studies reveal novel Ang1/Tie2 angiogenesis mechanisms, engineered exosome-nanoparticle platforms, and culture medium optimization for psoriasis-specific MSC potency.
Read More »A 2026 meta-analysis of 7 randomized trials confirms intradiscal MSC injections reduce chronic back pain and disability significantly. Meanwhile, bioengineered exosome therapies are redefining what cell-free disc regeneration looks like.
Read More »CRISPR-edited MSCs, iPSC-derived cells, combinatorial cell therapy, and exosome-based approaches are transforming PAD/CLI treatment. Six landmark 2026 papers and five active clinical trials reviewed for clinicians and researchers.
Read More »Pulmonary arterial hypertension kills half its patients within five years. 2026 research shows mesenchymal stem cells — especially HO-1-modified and mitochondria-primed MSCs — are reversing the vascular remodeling at the disease’s core. Here’s the science behind the breakthrough.
Read More »A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be available.
Read More »Stem cell therapy prices range from $2,000 to $100,000 depending on where you go. Here’s what actually drives the cost, what’s included, and how Thailand compares to the US, Australia, and Europe in 2026.
Read More »MSC therapy is offering new hope for IBD patients who don’t respond to conventional biologics. Here’s what the 2026 clinical data shows.
Read More »Kaempferol-modified MSC extracellular vesicles suppress ADAM10 and restore UV-damaged collagen. This is the future of anti-aging skin repair.
Read More »